Literature DB >> 29307645

The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo.

Nanja van Geel1, Marcel Bekkenk2, Janny E Lommerts2, Khaled Ezzedine3, John Harris4, Iltefat Hamzavi5, Viktoria Eleftheriadou6, Mauro Picardo7, Alain Taieb8, Cecilia A C Prinsen9, Albert Wolkerstorfer2, Reinhart Speeckaert10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29307645     DOI： 10.1016/j.jaad.2017.12.070

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  A deep learning-based hybrid artificial intelligence model for the detection and severity assessment of vitiligo lesions.

Authors:  Lifang Guo; Yin Yang; Hui Ding; Huiying Zheng; Hedan Yang; Junxiang Xie; Yong Li; Tong Lin; Yiping Ge
Journal:  Ann Transl Med       Date:  2022-05

2.  Skin Interstitial Fluid and Plasma Multiplex Cytokine Analysis Reveals IFN-γ Signatures and Granzyme B as Useful Biomarker for Activity, Severity and Prognosis Assessment in Vitiligo.

Authors:  Chau Yee Ng; Yen-Chuan Chiu; Yu-Pei Chan; Yu-Jr Lin; Pei-Han Chung; Wen-Hung Chung; Cheng-Lung Ku
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

3.  The time window for the reversal of depigmentation from aggravation to recovery in a non-small-cell lung cancer patient with pre-existing vitiligo using anti-programmed cell death-1 therapy: A case report.

Authors:  Zhiru Gao; Yinghui Xu; Jianjiao Zu; Xu Wang; Chao Sun; Shi Qiu; Ye Guo; Kewei Ma
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

4.  Reliability, Validity and Feasibility of the Vitiligo Extent Score (VES) and Self-Assessment Vitiligo Extent Score (SA-VES) Among Vitiligo Patients: A Cross-Cultural Validation.

Authors:  Pichanee Chaweekulrat; Narumol Silpa-Archa; Chalermkwan Apinuntham; Chayada Chaiyabutr; Chanisada Wongpraparut
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.